AHEPA
Thessaloniki, Greece
NCT Number: NCT04112511
The purpose of the study is to investigate the potential correlations of global longitudinal strain and peak left atrial strain, measured by speckle tracking echocardiography with the severity of hypertrophic cardiomyopathy and the risk for arrhythmias.
Specifically the investigational questions are:
1. Is there a correlation between myocardial deformation parameters of the left heart chambers with other important ultrasound parameters (eg maximal wall thickness, presence of subaortic obstruction, etc.) in patients with hypertrophic cardiomyopathy? 2. Is there a correlation between myocardial deformation parameters of the left heart chambers and the symptomatology or functional capacity of patients with hypertrophic cardiomyopathy? 3. Is there a correlation between the myocardial deformation parameters of the left heart chambers and the exercise capacity, as evidenced by the cardiopulmonary exercise test, in patients with hypertrophic cardiomyopathy? 4. Is there a correlation between myocardial deformation parameters of the left heart chambers with the risk of ventricular or supraventricular arrhythmias in patients with hypertrophic cardiomyopathy? 5. Is there a correlation between myocardial deformation parameters of the left heart chambers and risk factors for sudden death?
Looking for future studies?
Notify MeAll sexes
Observational
Thessaloniki, Greece
Myocardial deformation parameters of the left heart chambers are of particular clinical importance because of their possible association with the severity of HCM and the presence of arrhythmias. However,current literature appears conflicting.
This is a prospective cohort study aiming to examine the echocardiographic parameters of myocardial deformation, estimated by the "speckle tracking" method, and their correlation with clinical presentation and symptomatology, other imaging parameters, exercise capacity, arrhythmias (ventricular or supraventricular) and risk factors for sudden death in patients with hypertrophic cardiomyopathy.
Although, similar efforts have been made in international literature, they are scarce and their results contradictory. The present study is the first to be performed in a Greek population, a fact that is particularly important given the genetic heterogeneity of the disease.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-Patients with diagnosed hypertrophic cardiomyopathy
Exclusion criteria
Time frame: 3 years
Documented ventricular fibrillation or sustained ventricular tachycardia
Time frame: 3 years
Aproppriate Implantable cardioverter defibrillator therapy
Time frame: 3 years
Death by any cause
Time frame: 3 years
Death directly attributed to the primary disease
Time frame: 3 years
Documented atrial fibrillation in patients with prior sinus rythm
AHEPA University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04712136
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Montpellier, Occitanie, France
View Trial DetailsNCT06549608
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Vancouver, British Columbia, Canada
View Trial DetailsNCT04129905
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Pessac, France
View Trial DetailsNCT02590809
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Bordeaux, France
View Trial Details